Category - Executive Moves

Executive Moves

GeneTether bolsters management team to support growth

Closely held GeneTether, a genome editing technology company, named Roland Boivin as CEO, Jean Jen as CFO and Peter Sampson, Ph.D., as VP of research and development. The appointments are intended to further position...

October 19, 2021

Executive Moves

Daniel Pearlstein joins POINT Biopharma in corporate strategy

Daniel Pearlstein was named associate director, corporate strategy, of POINT Biopharma (NASDAQ:PNT), which debuted on the Nasdaq Capital Market on July 1, 2021. Mr. Pearlstein was formerly EVP for...

September 27, 2021

Executive Moves

IntelGenx strengthens board with atai appointments of Dr. Srinivas Rao and Frank Stegert

IntelGenx Technologies (TSXV:IGX; OTCQB:IGXT) named Dr. Srinivas (Srini) Rao, M.D., Ph.D., and Frank Stegert to the board, reflecting a previously disclosed purchaser rights agreement with atai Life Sciences AG. With...

August 4, 2021

Executive Moves

EyeGate Pharma names Brian Strem as president and CEO

Brian Strem EyeGate Pharmaceuticals (NASDAQ:EYEG) appointed Brian Strem, Ph.D., as president, CEO and a director, effective immediately. He replaces acting CEO, Franz Obermayr, Ph.D., who reassumes his position as...

July 28, 2021

Executive Moves

Kyle Mikson joins Canaccord Genuity as director, senior equity research

Kyle Mikson Canaccord Genuity appointed Kyle Mikson as a director, senior equity research analyst covering the life science tools and diagnostics sector. Mr. Mikson will focus on expanding the firm’s footprint on...

July 9, 2021

Executive Moves

Q32 Bio names Adam Cutler as CFO

Adam Cutler Closely-held Q32 Bio appointed Adam Cutler as chief financial officer, with responsibility for all aspects of its financial strategy and operations. Mr. Cutler has more than 20 years of experience in...

July 7, 2021

Executive Moves

Talkiatry names Jared Camins as CTO

Closely held Talkiatry, a leading mental health care provider that connects people with high-quality psychiatric care via telehealth or in-person, appointed Jared Camins as chief technology officer.

June 22, 2021

Executive Moves

PharmaJet names Paul LaBarre as VP global business development

Paul LaBarre PharmaJet named Paul LaBarre as VP of global business development to lead business development and commercialization strategies, replacing Melissa Malhame, who transitioned to a strategic advisory role for...

June 15, 2021

Executive Moves

Accelmed Partners bolsters senior HealthTech executive team

Eric Tansky, former managing director in Oppenheimer’s medical technology practice, has joined Accelmed Partners, a private equity firm in HealthTech, as a general partner, and Stephen Rubin, former co-head of...

June 14, 2021

Executive Moves

Doug Kleinberg joins BTIG healthcare investment banking

Doug Kleinberg Doug Kleinberg has joined BTIG’s healthcare investment banking unit as a managing director to focus on investment banking opportunities for corporate clients across biotech, biopharma and pharma. Mr...

May 24, 2021

Category - Executive Moves

Subscribe